Randomized clinical trial comparing percutaneous closure of patent foramen ovale (PFO) using the Amplatzer PFO Occluder with medical treatment in patients with cryptogenic embolism (PC-Trial): rationale and design

BACKGROUND: Several studies have shown an association of cryptogenic stroke and embolism with patent foramen ovale (PFO), but the question how to prevent further events in such patients is unresolved. Options include antithrombotic treatment with warfarin or antiplatelet agents or surgical or endova...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Khattab, Ahmed A, Windecker, Stephan, Jüni, Peter, Hildick-Smith, David, Dudek, Dariusz, Andersen, Henning R, Ibrahim, Reda, Schuler, Gerhard, Walton, Antony S, Wahl, Andreas, Mattle, Heinrich P, Meier, Bernhard
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2011
Soggetti:
Study Protocol
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3058012/
https://ncbi.nlm.nih.gov/pubmed/21356042
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1745-6215-12-56
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi